Trial
NCT06715462
Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Eurofarma Laboratorios S.A.
Collaborators
—
Condition
Painful Diabetic Peripheral Neuropathy (PDPN)
Intervention
N0750
Why stopped
Strategic change in development priorities
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-18